Core Laboratories Inc. /DE/ Quarterly Income Tax Expense (Benefit) in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Core Laboratories Inc. /DE/ quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2022 to Q3 2024.
  • Core Laboratories Inc. /DE/ Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $4.69M, a 104% increase year-over-year.
  • Core Laboratories Inc. /DE/ Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $10.1M.
  • Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2023 was -$4.19M, a 141% decline from 2022.
  • Core Laboratories Inc. /DE/ annual Income Tax Expense (Benefit) for 2022 was $10.3M, a 35.2% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $10.1M $4.69M +$2.39M +104% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-24
Q2 2024 $7.73M $3.61M +$10.9M Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-25
Q1 2024 -$3.14M $1.66M +$1.05M +172% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 -$4.19M $159K Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $2.31M -$1.55M -40.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-24
Q2 2023 -$7.26M -$9.05M -506% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-25
Q1 2023 $610K Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q3 2022 $3.86M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $1.79M Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.